NASDAQ: MYGNMyriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?
Insider buying vs selling
Have Myriad Genetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark Verratti | Chief Commercial Officer | 2024-04-14 | 1,076 | $19.55 | $21.04kSell |
| Dale Muzzey | Chief Scientific Officer | 2024-04-14 | 940 | $19.55 | $18.38kSell |
| Natalie Munk | Chief Accounting Officer | 2024-04-06 | 581 | $20.26 | $11.77kSell |
| Natalie Munk | Chief Accounting Officer | 2024-03-25 | 363 | $21.98 | $7.98kSell |
| Mark Verratti | Chief Commercial Officer | 2024-03-24 | 1,584 | $22.24 | $35.23kSell |
| Paul J. Diaz | President and CEO | 2024-03-24 | 27,233 | $22.24 | $605.66kSell |
| Paul J. Diaz | President and CEO | 2024-03-24 | 18,589 | $22.24 | $413.42kSell |
| Dale Muzzey | Chief Scientific Officer | 2024-03-24 | 382 | $22.24 | $8.50kSell |
| Dale Muzzey | Chief Scientific Officer | 2024-03-24 | 561 | $22.24 | $12.48kSell |
| Kevin Richard Haas | Chief Technology Officer | 2024-03-24 | 1,718 | $22.24 | $38.21kSell |
MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MYGN insiders and whales buy or sell their stock.
MYGN Shareholders
What type of owners hold Myriad Genetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 16.31% | 14,658,349 | $272.65M | Institution |
| Vanguard Group Inc | 11.08% | 9,954,233 | $185.15M | Institution |
| Camber Capital Management LP | 8.50% | 7,635,000 | $142.01M | Institution |
| Wellington Management Group LLP | 8.03% | 7,219,706 | $134.29M | Institution |
| Glenview Capital Management LLC | 5.88% | 5,283,982 | $98.28M | Institution |
| State Street Corp | 5.23% | 4,700,631 | $87.43M | Institution |
| Earnest Partners LLC | 4.35% | 3,913,913 | $72.80M | Institution |
| Millennium Management LLC | 3.85% | 3,461,337 | $64.38M | Institution |
| Bank Of America Corp | 3.32% | 2,985,897 | $55.54M | Institution |
| Dimensional Fund Advisors LP | 2.98% | 2,680,918 | $49.87M | Institution |
MYGN vs Diagnostic & Research Stocks
Myriad Genetics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.